Cited by 1,192Atrial Fibrillation Management and OutcomesAcute Ischemic Stroke ManagementVenous Thromboembolism Diagnosis and Management

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study

Friberg, Leif, Rosenqvist, Mårten, Lip, Gregory Y.H.·2012·European Heart Journal

DOI 10.1093/eurheartj/ehr488

Open this paper in CoChat — free account

Abstract

Aims The impact of some risk factors for stroke and bleeding, and the value of stroke and bleeding risk scores, in atrial fibrillation (AF), has been debated, as clinical trial cohorts have not adequately tested these. Our objective was to investigate risk factors for stroke and bleeding in AF, and application of the new CHA(2)DS(2)-VASc and HAS-BLED schemes for stroke and bleeding risk assessments, respectively. Methods and results We used the Swedish Atrial Fibrillation cohort study, a nationwide cohort study of 182 678 subjects with a diagnosis of AF at any Swedish hospital between 1 July 2005 and 31 December 2008, who were prospectively followed for an average of 1.5 years (260 000 years at risk). With the use of the National Swedish Drug Registry, all patients who used an oral anticoagulant anytime during follow-up were identified. Most of the analyses were made on a subset of 90 490 patients who never used anticoagulants. Risk factors for stroke, the composite thromboembolism endpoint (stroke, TIA, or systemic embolism), and bleeding, and the performance of published stroke and bleeding risk stratification schemes were investigated. On multivariable analysis, significant associations were found between the following 'new' risk factors and thromboembolic events; peripheral artery disease [hazard ratio (HR) 1.22 (95% CI 1.12-1.32)], 'vascular disease' [HR 1.14 (1.06-1.23)], prior myocardial infarction [HR 1.09 (1.03-1.15)], and female gender [HR 1.17 (1.11-1.22)]. Previou…

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehr488

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Dabigatran versus warfarin in patients with atrial fibrillation
Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905561 · Cited by 11,215
Apixaban versus warfarin in patients with atrial fibrillation
Granger, C. B., Alexander, J. H., McMurray, J. J. V., Lopes, R. D., Hylek, E. M., Hanna, M., Al-Khalidi, H. R., Ansell, J., Atar, D., Avezum, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107039 · Cited by 8,943
Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach
Lip, G. Y. H., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. G. M. (2010) · Chest · doi:10.1378/chest.09-1584 · Cited by 6,879
Self-citation
Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond
Pencina, M. J., D' Agostino, R. B., D' Agostino, R. B., & Vasan, R. S. (2008) · Statistics in Medicine · doi:10.1002/sim.2929 · Cited by 6,493
Guidelines for the management of atrial fibrillation
Authors/Task Force Members, Camm, A. J., Kirchhof, P. F., Lip, G. Y. H., Schotten, U., Savelieva, I., Ernst, S., Gelder, I. C. V., Al‐Attar, N., Hindricks, G., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq278 · Cited by 5,954
Self-citation
Validation of Clinical Classification Schemes for Predicting Stroke: Results From the National Registry of Atrial Fibrillation
Gage, B. F., Waterman, A. D., Shannon, W., Boechler, M., Rich, M. W., & Radford, M. J. (2001) · JAMA · doi:10.1001/jama.285.22.2864 · Cited by 4,832
A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation
Pisters, R., Lane, D. A., Nieuwlaat, R., de Vos, C. B., Crijns, H. J. G. M., & Lip, G. Y. H. (2010) · CHEST Journal · doi:10.1378/chest.10-0134 · Cited by 4,517
Self-citation
Effect of clopidogrel added to aspirin in patients with atrial fibrillation
The ACTIVE Investigators (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901301 · Cited by 2,102
Comments on ‘Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond’ by M. J. Pencina, R. B. D'Agostino Sr, R. B. D'Agostino Jr, R. S. Vasan, Statistics in Medicine (DOI: 10.1002/sim.2929)
Greenland, P. (2007) · Statistics in Medicine · doi:10.1002/sim.2976 · Cited by 1,300
Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation
Lip, G. Y. H., Frison, L., Halperin, J. L., & Lane, D. A. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.09.024 · Cited by 1,077
Self-citation

Show all 48 references

Research works printed but not linked: 2

Atrial Fibrillation Investigators, 1994, Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation analysis of pooled data from five randomised clinical trials, Arch Intern Med, 154, 1949
National Collaborating Centre for Chronic Conditions, 2006, Atrial Fibrillation: National Clinical Guideline for Management in Primary and Secondary Care

Sorted by citations

Items 601–700 of 999

Left atrial appendage occlusion in patients with atrial fibrillation and previous Intracranial Hemorrhage or Cerebral Amyloid Angiopathy: A systematic review and meta-analysis
Mavridis, T., Barakakis, P. A., Chlorogiannis, D., & Charidimou, A. (2025) · International Journal of Stroke · doi:10.1177/17474930251360076 · Cited by 9
Improving stroke risk prediction in atrial fibrillation with circulating biomarkers: the CHA2DS2-VASc–Biomarkers model
Short, S., Wilkinson, K. S., Hald, E. M., Howard, G., Howard, V. J., Judd, S. E., Soliman, E. Z., D, B. M. K. M., Robinson, D., Stanton, R. J., et al. (2025) · Journal of Thrombosis and Haemostasis · doi:10.1016/j.jtha.2025.06.007 · Cited by 9
Could anticoagulation avoid bioprosthesis subclinical thrombosis in patients undergoing transcatheter aortic valve replacement?
Huchet, F., Letocart, V., Guérin, P., Cueff, C., Roy-Giocosa, J., Guyomarch, B., Jaafar, P., & Manigold, T. (2017) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2017.03.006 · Cited by 9
CHA2DS2-VASc versus CHADS2 for stroke risk assessment in low-risk patients with atrial fibrillation: a pilot study from a single center of the NCDR-PINNACLE registry
Piyaskulkaew, C., Singh, T., Szpunar, S. M., Saravolatz, L. D., & Rosman, H. (2013) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-013-0983-z · Cited by 9
SAFETY OF LONG-TERM THERAPY WITH WARFARIN: HEMORRHAGE FREQUENCY AND CLINICAL PREDICTORS (results of a prospective 15-year follow-up)
Станиславовна, К. Е., Zemlyanskaya, O. A., Панченко, Е. П., Борисович, Д. А., & Krivosheeva, E. N. (2017) · Aterotromboz = Atherothrombosis · doi:10.21518/2307-1109-2017-1-145-162 · Cited by 9
Evaluation of the predictive performance of bleeding risk scores in patients with non‐valvular atrial fibrillation on oral anticoagulants
Beshir, S. A., Aziz, Z., Yap, L. B., Chee, K. H., & Lo, Y. L. (2017) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12634 · Cited by 10
Usefulness of the Addition of Renal Function to the CHA2DS2-VASc Score as a Predictor of Thromboembolism and Mortality in Patients Without Atrial Fibrillation
Parsons, C. E., Cha, S., Shen, W.-K., Chamberlain, A. M., Luis, S. A., Keddis, M. T., & Shamoun, F. E. (2018) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2018.04.049 · Cited by 9
Direct-Acting Oral Anticoagulants in Atrial Fibrillation
Ferrari, F., da Silveira, A. D., Martins, V. M., Franzoni, L. T., Zimerman, L. I., & Stein, R. (2020) · Cardiology in Review · doi:10.1097/crd.0000000000000312 · Cited by 10
The cost-effectiveness of one-time opportunistic screening for atrial fibrillation in different age cohorts of inhabitants in Denmark aged 65 years and above: a Markov modelled analysis
Sciera, L. K., Frost, L., Dybro, L., & Poulsen, P. B. (2020) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcaa092 · Cited by 9
Dose specific effectiveness and safety of DOACs in patients with non-valvular atrial fibrillation: A Canadian retrospective cohort study
Rahme, E., Godin, R., Nedjar, H., Dasgupta, K., & Tagalakis, V. (2021) · Thrombosis Research · doi:10.1016/j.thromres.2021.05.005 · Cited by 9
External validation of bleeding risk models for the prediction of long-term bleeding risk in patients with established cardiovascular disease
Castelijns, M. C., Hageman, S. H. J., Teraa, M., van der Meer, M. G., Westerink, J., Costa, F., ten Berg, J. M., & Visseren, F. L. J. (2023) · American Heart Journal · doi:10.1016/j.ahj.2023.02.011 · Cited by 9
Association of the ASCO Classification with the Executive Function Subscores of the Montreal Cognitive Assessment in Patients with Postischemic Stroke
Washida, K., Ihara, M., Tachibana, H., Sekiguchi, K., Kowa, H., Kanda, F., & Toda, T. (2014) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2014.04.009 · Cited by 9
Stroke prevention in atrial fibrillation: changing concepts
Lip, G. Y. H. (2015) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvu003 · Cited by 9
Self-citation
Atrial fibrillation decision support tool: Population perspective
Eckman, M. H., Costea, A., Attari, M., Munjal, J., Wise, R. E., Knochelmann, C., Flaherty, M. L., Baker, P., Ireton, R., Harnett, B. M., et al. (2017) · American Heart Journal · doi:10.1016/j.ahj.2017.08.016 · Cited by 9
CHA2DS2-VASc score performance to predict stroke after acute decompensated heart failure with and without reduced ejection fraction
Berkovitch, A., Mazin, I., Younis, A., Nir, S., Nof, E., Goldenberg, I., & Beinart, R. (2019) · EP Europace · doi:10.1093/europace/euz192 · Cited by 9
The New Canadian Cardiovascular Society Algorithm for Antithrombotic Therapy of Atrial Fibrillation Is Appropriately Based on Current Epidemiologic Data
Cairns, J. A., Healey, J. S., Macle, L., Mitchell, L. B., & Verma, A. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.11.021 · Cited by 9
Hyperthyroid Atrial Fibrillation: Does It Matter for Stroke Risk?
Poulin, M., & Doukky, R. (2014) · Cardiology · doi:10.1159/000357613 · Cited by 9
Relevance of High Bleeding Risk and Postdischarge Bleeding in Patients Undergoing Percutaneous Coronary Intervention
Ingraham, B. S., Valgimigli, M., Angiolillo, D. J., Capodanno, D., Rao, S. V., Urban, P. M., & Singh, M. (2025) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2024.09.010 · Cited by 8
Stroke/Thromboembolism and Intracranial Hemorrhage in a Real-world Atrial Fibrillation Population
Palareti, G., Salomone, L., Cavazza, M., Guidi, M., Muscari, A., Boriani, G., Micoli, A. D., Guizzardi, G., Procaccianti, G., Guidetti, A. M., et al. (2014) · CHEST Journal · doi:10.1378/chest.13-2443 · Cited by 8
Self-citation
Using Direct Oral Anticoagulants in Patients with Atrial Fibrillation: Assessment, Monitoring and Treatment Reversal
Martínez‐Rubio, A., Alcazar, M. D., Cadena, A. S., & Martínez-Torrecilla, R. (2016) · European Cardiology Review · doi:10.15420/ecr.2016:30:1 · Cited by 8
How do aging and comorbidities impact risk of ischemic stroke in patients with atrial fibrillation
Liao, J., Chao, T., & Chen, S. (2018) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2018.11.003 · Cited by 8
Atrial Fibrillation Management: A Comprehensive Review with a Focus on Pharmacotherapy, Rate, and Rhythm Control Strategies
Lacoste, J. L., Szymanski, T. W., Avalon, J. C., Kabulski, G. M., Kohli, U., Marrouche, N. F., Singla, A., Balla, S., & Jahangir, A. (2022) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-022-00529-6 · Cited by 8
Cost-Effectiveness Analysis of Pharmacogenomics (PGx)-Based Warfarin, Apixaban, and Rivaroxaban Versus Standard Warfarin for the Management of Atrial Fibrillation in Ontario, Canada
Hafeez, A., Cipriano, L. E., Kim, R. B., Zaric, G. S., Schwarz, U. I., & Sarma, S. (2023) · PharmacoEconomics · doi:10.1007/s40273-023-01309-z · Cited by 8
Initial results of transcatheter modification of left atrial appendage by obliteration with device in patients with nonvalvular atrial fibrillation: Real-world data from the TERMINATOR registry
Hara, H., Kubo, S., Nakajima, Y., Matsumoto, T., Kondo, Y., Sugane, H., Okubo, K., Nakagawa, K., Nagatomo, D., Hachinohe, D., et al. (2023) · Journal of Cardiology · doi:10.1016/j.jjcc.2023.09.010 · Cited by 8
Outcomes of Left Atrial Appendage Closure in Hemodialysis Patients With Atrial Fibrillation
Tanaka, S., Imamura, T., Fukuda, N., Ueno, H., Kinugawa, K., Sago, M., Chatani, R., Hachinohe, D., Naganuma, T., Ohno, Y., et al. (2025) · JACC Asia · doi:10.1016/j.jacasi.2024.10.022 · Cited by 8
Patients with atrial fibrillation and outcomes of cerebral infarction in those with treatment of warfarin versus no warfarin with references to CHA2DS2-VASc score, age and sex - A Swedish nationwide observational study with 48 433 patients
Andersson, T., Magnuson, A., Bryngelsson, I., Fröbert, O., Henriksson, K. M., Edvardsson, N. G., & Poçi, D. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176846 · Cited by 8
Anemia: An Independent Predictor Of Adverse Outcomes In Older Patients With Atrial Fibrillation.
Ali, A., Athavale, N. V., & Abdelhafiz, A. H. (2016) · PubMed Central · doi:10.4022/jafib.1366 · Cited by 8
Restarting Therapeutic Anticoagulation After Elective Craniotomy for Patients with Chronic Atrial Fibrillation: A Review of the Literature
Mehta, V. A., Wang, T. Y., Sankey, E. W., Howell, E., Goodwin, C. R., Levy, J. H., & Friedman, A. H. (2020) · World Neurosurgery · doi:10.1016/j.wneu.2020.01.235 · Cited by 8
Atrial fibrillation dashboard evaluation using the think aloud protocol
de Lusignan, S., Liyanage, H., Sherlock, J., Ferreira, F. M., Munro, N. M., Feher, M. D., & Hobbs, R. F. (2020) · BMJ Health & Care Informatics · doi:10.1136/bmjhci-2020-100191 · Cited by 8
Impact of timing of atrial fibrillation, CHA2DS2-VASc score and cancer therapeutics on mortality in oncology patients
Hussain, M., Misbah, R., Donnellan, E., Alkharabsheh, S. K., Hou, Y., Cheng, F., Crookshanks, M., Watson, C. J., Toth, A. J., Houghtaling, P. L., et al. (2020) · Open Heart · doi:10.1136/openhrt-2020-001412 · Cited by 8
Gender difference in left atrial appendage occlusion outcomes: Results from the Amplatzer™ Amulet™ Observational Study
Caterina, A. R. D., Nielsen‐Kudsk, J. E., Schmidt, B., Mazzone, P., Fischer, S., Lund, J., Montorfano, M., Gage, R., Lam, S. C. C., & Berti, S. L. (2021) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2021.100848 · Cited by 8
The IMPact of untReated nOn-Valvular atrial fibrillation on short-tErm clinical and economic outcomes in the US Medicare population: the IMPROVE-AF model
Sussman, M., Fusco, M. D., Tao, C. Y., Guo, J. D., Gillespie, J. A., Ferri, M., Adair, N., Cato, M., Shirkhorshidian, I., & Barnes, G. D. (2021) · Journal of Medical Economics · doi:10.1080/13696998.2021.1970954 · Cited by 8
Comparative Effectiveness and Safety of Low-Dose Oral Anticoagulants in Patients With Atrial Fibrillation
Perreault, S., Dragomir, A., Côté, R., Lenglet, A., de Denus, S., Dorais, M., White‐Guay, B., Brophy, J. M., Schnitzer, M. E., Dubé, M., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.812018 · Cited by 8
Cost-effectiveness of a photopethysmographic procedure for screening for atrial fibrillation in 6 European countries
Wahler, S., Birkemeyer, R., Alexopoulos, D. K., Siudak, Z., Müller, A., & von der Schulenburg, J.-M. (2022) · Health Economics Review · doi:10.1186/s13561-022-00362-2 · Cited by 8
Left Atrial Diameter in the Prediction of Thromboembolic Event and Death in Atrial Fibrillation
Krittayaphong, R., Winijkul, A., & Sairat, P. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11071838 · Cited by 8
Barriers to prescribing oral anticoagulants to inpatients aged 80 years and older with nonvalvular atrial fibrillation: a cross-sectional study
Xia, X., Wang, L., Lin, T., Yue, J., Yang, Z., Mi, C., Liao, Z., Chen, Y., Ge, N., & Wu, C. (2022) · BMC Geriatrics · doi:10.1186/s12877-022-02965-0 · Cited by 8
Efficacy and Safety of Clinically Driven Low-Dose Treatment with Direct Oral Anticoagulants in Asians with Atrial Fibrillation: a Systematic Review and Meta-analysis
Choi, J., No, J. E., Lee, J., Choi, S. A., Chung, W., Ah, Y., & Yu, Y. M. (2021) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-021-07171-5 · Cited by 8
Rule-based definition of muscle bundles in patient-specific models of the left atrium
Rossi, S., Abdala, L., Woodward, A., Vavalle, J. P., Henriquez, C. S., & Griffith, B. E. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.912947 · Cited by 8
Screening for atrial fibrillation to prevent stroke in elderly individuals with or without preexisting cardiovascular disease: A post hoc analysis of the randomized LOOP Study
Xing, L. Y., Diederichsen, S. Z., Højberg, S., Krieger, D. W., Graff, C., Olesen, M. S., Brandes, A., Køber, L., Haugan, K., & Svendsen, J. H. (2022) · International Journal of Cardiology · doi:10.1016/j.ijcard.2022.10.167 · Cited by 8
Sex Differences in the Combined Ablation and Left Atrial Appendage Closure
Chen, M., Sun, J., Li, W., Zhang, P., Zhang, R., Mo, B., Yang, M., Wang, Q., & Li, Y. (2023) · JACC Asia · doi:10.1016/j.jacasi.2022.10.011 · Cited by 8
Oral Anticoagulation in Patients With Advanced Chronic Kidney Disease and Atrial Fibrillation: Beyond Anticoagulation
Dhaese, S. A. M., & Vriese, A. S. D. (2023) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2023.01.007 · Cited by 9
Association of Direct Oral Anticoagulation Management Strategies With Clinical Outcomes for Adults With Atrial Fibrillation
Derington, C. G., Goodrich, G. K., Xu, S., Clark, N. P., Reynolds, K., An, J., Witt, D. M., Smith, D. H., O'Keeffe-Rosetti, M. C., Lang, D. T., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.21971 · Cited by 8
Novel Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation
Jalota, A., Scarabelli, T. M., Saravolatz, L. D., Bakhsh, M. U., Agrawal, P., Jalota, R., Chen-Scarabelli, C. A., Fuster, V., & Halperin, J. L. (2014) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-014-6524-y · Cited by 8
Biomarkers Associated with Bleeding Risk in the Setting of Atrial Fibrillation
Sideris, S. K., Archontakis, S., Latsios, G., Lazaros, G. A., Toutouzas, K. P., Tsiamis, E. G., Vavuranakis, M., Vlachopoulos, C., Gatzoulis, K. A., Tsioufis, C., et al. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867324666170718124742 · Cited by 8
Should Every Patient With Atrial Fibrillation and a CHA2DS2-VASc Score of 1 Be Anticoagulated? A Systematic Review of 37,030 Patients
Neefs, J., Klamer, T. A., Krul, S. P. J., & de Groot, J. R. (2019) · Cardiology in Review · doi:10.1097/crd.0000000000000246 · Cited by 8
New-Onset Atrial Fibrillation Among Patients With Infection in the Emergency Department: A Multicenter Cohort Study of 1-Year Stroke Risk
Hansen, T., Pottegård, A., Brandes, A., Ekelund, U. E. G., Kildegaard, H., Forberg, J. L., Brabrand, M., & Lassen, A. T. (2019) · The American Journal of Medicine · doi:10.1016/j.amjmed.2019.06.048 · Cited by 8
One More “C” for CHA2DS2-VASc Score?
Siu, C. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.12.067 · Cited by 8
Very Elderly Patients With Atrial Fibrillation Treated With Edoxaban
Denas, G., Zoppellaro, G., Granziera, S., Pagliani, L., Noventa, F., Iliceto, S., & Pengo, V. (2023) · JACC Advances · doi:10.1016/j.jacadv.2023.100569 · Cited by 7
Predicting stroke risk after sepsis hospitalization with new‐onset atrial fibrillation
Myers, L. C., Peltan, I. D., Thai, K. K., Kipnis, P., Desai, M., Devis, Y., Clancy, H., Lu, Y., Brown, S. M., Go, A. S., et al. (2024) · Journal of Hospital Medicine · doi:10.1002/jhm.13343 · Cited by 7
Gender Differences in the Trends of Hospitalizations for Acute Stroke Among Patients With Atrial Fibrillation in the United States: 2005 to 2014
Shantha, G. P. S., Mentias, A. G., Bhise, V., Kumar, A., Rasmussen, T. P., Adams, C., Chaikriangkrai, K., Mohsen, A., Alqasrawi, M., Sigurðsson, G., et al. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.07.044 · Cited by 8
Initiation of oral anticoagulation in US older adults newly diagnosed with atrial fibrillation during hospitalization
Troy, A. L., Herzig, S. J., Trivedi, S., & Anderson, T. S. (2023) · Journal of the American Geriatrics Society · doi:10.1111/jgs.18375 · Cited by 7
Can a best practice advisory improve anticoagulation prescribing to reduce stroke risk in patients with atrial fibrillation?
Eckman, M. H., Wise, R., Knochelmann, C., Mardis, R., Leonard, A. C., Wright, S., Gummadi, A., Dixon, E., Becker, R. C., Schauer, D. P., et al. (2023) · Journal of Cardiology · doi:10.1016/j.jjcc.2023.08.005 · Cited by 7
How to Manage Antiplatelet Therapy for Stenting in a Patient Requiring Oral Anticoagulants
Faxon, D. P. (2012) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-012-0222-5 · Cited by 7
THE EFFICACY OF LONG-TERM WARFARIN THERAPY: THE IMPACT ON THE INCIDENCE OF ISCHEMIC CEREBROVASCULAR DISORDERS AND CLINICAL PREDICTORS OF DEVELOPING SUCH DISORDERS. (Results of a prospective 10-year follow-up study)
Станиславовна, К. Е., Zemlyanskaya, O. A., Dobrovolsky, A. B., & Панченко, Е. П. (2017) · Aterotromboz = Atherothrombosis · doi:10.21518/2307-1109-2017-2-115-130 · Cited by 7
Heart Failure: A Weak Link in CHA2DS2-VASc
Friberg, L., & Lund, L. H. (2018) · ESC Heart Failure · doi:10.1002/ehf2.12262 · Cited by 7
Self-citation
Methodologic Differences Across Studies of Patients With Atrial Fibrillation Lead to Varying Estimates of Stroke Risk
Quinn, G. R., Severdija, O. N., Chang, Y., Dallalzadeh, L. O., & Singer, D. E. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.117.007537 · Cited by 7
2014 Indonesian Heart Association Guidelines of Management of Atrial Fibrillation
Yuniadi, Y., Hanafy, D. A., Rahardjo, S. B., Tondas, A. E., Maharani, E., Hermanto, D. Y., & Munawar, M. (2015) · Indonesian Journal of Cardiology · doi:10.30701/ijc.v35i2.398 · Cited by 7
N-terminal pro-brain natriuretic peptide levels had an independent and added ability in the evaluation of all-cause mortality in older Chinese patients with atrial fibrillation
Fu, S., Jiao, J., Guo, Y., Zhu, B., & Luo, L. (2019) · BMC Geriatrics · doi:10.1186/s12877-019-1051-0 · Cited by 7
Left atrial appendage closure in atrial fibrillation patients with prior major bleeding or ineligible for oral anticoagulation
Wintgens, L. I. S., Vorselaars, V. M. M., Klaver, M. N., Swaans, M. J., Alipour, A., Rensing, B. J. W. M., Post, M. C., & Boersma, L. V. A. (2019) · Netherlands Heart Journal · doi:10.1007/s12471-019-1295-5 · Cited by 7
Bleeding in patients with atrial fibrillation treated with combined antiplatelet and anticoagulant therapy: time to turn the corner
Xu, K., & Chan, N. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.07.40 · Cited by 8
Use of oral anticoagulation therapy in the first 3 months after the diagnosis of atrial fibrillation in Israel: A population‐based study
Kezerle, L., Tsadok, M. A., Senderey, A. B., Hoshen, M., Leventer‐Roberts, M., Reges, O., Leibowitz, M., & Haim, M. (2020) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.14452 · Cited by 7
Prevalence of Acute Coronary Syndrome and Various Risk Factors in Acute Stroke Patients
Rashid, M. H., Yaseen, G., Ghaffar, U., Khan, A. A., Ahmad, K., Aisha, A., & Komel, A. (2020) · Cureus · doi:10.7759/cureus.9552 · Cited by 7
Effectiveness and safety of low-dose versus standard-dose rivaroxaban and apixaban in patients with atrial fibrillation
Perreault, S., Côté, R., Dragomir, A., White‐Guay, B., Lenglet, A., & Dorais, M. (2022) · PLoS ONE · doi:10.1371/journal.pone.0277744 · Cited by 7
Device-detected atrial fibrillation in a large remote-monitored cohort: implications for anticoagulation and need for new pathways of service delivery
O’Shea, C., Brooks, A. G., Middeldorp, M. E., Harper, C., Hendriks, J., Russo, A. M., Freeman, J. V., Gopinathannair, R., Varma, N., Deering, T. F., et al. (2023) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-023-01481-4 · Cited by 7
Long-term outcomes of successful left atrial appendage occlusion with focus on stroke prevention: 10-year follow-up of a single-center registry
Maarse, M., Aarnink, E. W., Huijboom, M., Abeln, B. G. S., Staal, D. P., Rensing, B. J. W. M., Kerklaan, J. P., van Dijk, V. F., Swaans, M. J., & Boersma, L. V. A. (2023) · Heart Rhythm O2 · doi:10.1016/j.hroo.2023.03.002 · Cited by 7
New Oral Anticoagulants
Ferns, S. J., & Naccarelli, G. V. (2015) · Medical Clinics of North America · doi:10.1016/j.mcna.2015.02.006 · Cited by 8
Budget impact analysis resulting from the use of dabigatran etexilate in preventing stroke in patients with non-valvular atrial fibrillation in Italy
Mennini, F. S., Russo, S., & Marcellusi, A. (2012) · Farmeconomia Health economics and therapeutic pathways · doi:10.7175/fe.v13i3.268 · Cited by 7
Dabigatran in nonvalvular atrial fibrillation
Mumoli, N., Mastroiacovo, D., Permunian, E. T., Vitale, J., Giorgi‐Pierfranceschi, M., Cei, M., & Dentali, F. (2017) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000524 · Cited by 7
Association between activated partial thromboplastin time, age and bleeding events in NVAF patients receiving dabigatran
Ji, Q., Xu, Q., Wang, Z., Li, X., & Lv, Q. (2018) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-018-2583-5 · Cited by 7
Current Predictors of Atrial Fibrillation Progression
Podzolkov, V. I., & Tarzimanova, A. I. (2019) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2019-15-2-149-158 · Cited by 7
Risk of ischaemic stroke in thyrotoxic atrial fibrillation
Chen, Z., Wu, N., Chang, C., Ho, C., Liao, C., Chiang, C., & Chang, W. (2019) · Clinical Endocrinology · doi:10.1111/cen.14061 · Cited by 7
Management of anticoagulation and antiplatelet agents in the radical cystectomy patient
Smelser, W., & Jones, C. P. (2020) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2019.12.011 · Cited by 7
The development and validation of a multivariable model to predict the bleeding risk score for patients with non-valvular atrial fibrillation using direct oral anticoagulants in the Arab population
Alammari, M., Sultana, K., Alturaiki, A., Thomas, A., Albabtain, M. A., AlAyoubi, F., & Richi, H. (2021) · PLoS ONE · doi:10.1371/journal.pone.0250502 · Cited by 8
Clinical Outcomes of Very Elderly Patients With Atrial Fibrillation Receiving On‐label Doses of Apixaban: J‐ELD AF Registry Subanalysis
Okada, M., Inoue, K., Tanaka, N., Sakata, Y., Akao, M., Yamashita, T., Suzuki, S. S., Okumura, K., & J‐ELD AF investigators (2021) · Journal of the American Heart Association · doi:10.1161/jaha.121.021224 · Cited by 7
Comparison of the HAS‐BLED versus ORBIT scores in predicting major bleeding among Asians receiving direct‐acting oral anticoagulants
Wattanaruengchai, P., Nathisuwan, S., Karaketklang, K., Wongcharoen, W., Phrommintikul, A., & Lip, G. Y. H. (2021) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.15145 · Cited by 7
Self-citation
Efficacy and cost-effectiveness of new oral anticoagulants compared to warfarin for the prevention of stroke in patients with atrial fibrillation
Wisløff, T. F., Ringerike, T., Hagen, G., Reikvam, Å., & Klemp, M. (2013) · NORA - Norwegian Open Research Archives · Cited by 7
Effects of Atrial Fibrillation and Sinus Rhythm on Cardiac Remodeling and Valvular Regurgitation
Marwick, T. H., & Brugger, N. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.12.028 · Cited by 7
The Impact of Longitudinal Data‐Completeness of Electronic Health Record Data on the Prediction Performance of Clinical Risk Scores
Jin, Y., Weberpals, J. G., Wang, S. V., Desai, R. J., Merola, D., & Lin, K. J. (2023) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2901 · Cited by 7
The Impact of Atherosclerotic Burden on Vascular Outcomes in Patients with Stroke and Atrial Fibrillation: The ATHENA study
Rigutini, A. G., RAF NOAC Investigators, Rigutini, A. G., Paciaroni, M., Cancelloni, V., Lip, G. Y. H., Abdul‐Rahim, A. H., Agnelli, G., Becattini, C., Tsivgoulis, G. K., et al. (2024) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/10760296241240746 · Cited by 6
Self-citation
Scientific statement from the French neurovascular and cardiac societies for improved detection of atrial fibrillation after ischaemic stroke and transient ischaemic attack
Gaillard, N., Deharo, J., Suissa, L., Defaye, P., Sibon, I., Leclercq, C., Alamowitch, S., Guidoux, C., & Cohen, A. A. (2024) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2024.06.002 · Cited by 6
Trends in stroke-related mortality in atrial fibrillation patients in the United States: Insights from the CDC WONDER database
Naveed, M. A., Neppala, S., Chigurupati, H. D., Rehan, M. O., Ali, A., Naveed, H., Azeem, B., Iqbal, R., Mubeen, M., Ahmed, M., et al. (2024) · American Heart Journal Plus Cardiology Research and Practice · doi:10.1016/j.ahjo.2024.100491 · Cited by 6
Impact of Anemia on Clinical Outcomes in Atrial Fibrillation Patients on Oral Anticoagulants: A Prognostic Meta‐Analysis
Amin, A. M., Elbenawi, H., Odat, R. M., Elgebaly, M., Al‐Shammari, A. S., Manasrah, A., Nakhla, M., Ayman, D., Ali, M. A., Helmi, A., et al. (2024) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.16537 · Cited by 6
Short- and long-term outcomes of percutaneous left atrial appendage occlusion in cancer patients
Tinoco, M. G., Echarte‐Morales, J., Guerreiro, C., Gil, E. M. A., Caneiro‐Queija, B., Barreiro‐Pérez, M., González-Ferreiro, R., Fernández, S., Sáez, A. O., Díaz, V. A. J., et al. (2024) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2024.101585 · Cited by 6
Direct oral anticoagulants versus Vitamin K antagonist in kidney transplant recipients with atrial fibrillation: A study from a global federated research network
Rossi, M., Tartaglia, E., Askarinejad, A., Rigutini, A. G., Alobaida, M., Rao, A., Oni, L., Ferri, C., Bucci, T., & Lip, G. Y. H. (2026) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2026.106751 · Cited by 7
Self-citation
Chinese Guidelines for the Diagnosis and Management of Atrial Fibrillation
Chinese Society of Cardiology, C. M. A., & Heart Rhythm Committee of Chinese Society of Biomedical Engineering (2024) · Cardiology Discovery · doi:10.1097/cd9.0000000000000123 · Cited by 7
Left atrial appendage closure for patients with atrial fibrillation at high intracranial haemorrhagic risk
Fouks, A. A., Yaghi, S. R., Gökçal, E., Das, A. S., Rotschild, O., Silverman, S. B., Singhal, A. B., Romero, J. E., Kapur, S., Greenberg, S. M., et al. (2024) · Stroke and Vascular Neurology · doi:10.1136/svn-2024-003142 · Cited by 6
Atrial Fibrillation in Heart Failure in the Older Population
Heck, P. M., Lee, J., & Kistler, P. M. (2013) · Heart Failure Clinics · doi:10.1016/j.hfc.2013.07.007 · Cited by 6
[Success rate of one-stop procedure for atrial fibrillation ablation and its impact on cardiac function: a propensity-matched study].
Zhu, S., Zheng, M., Yan, R., Tan, Z., Zhao, H., Zhang, J., & Peng, J. (2020) · PubMed Central · doi:10.12122/j.issn.1673-4254.2020.10.06 · Cited by 6
Influence of gender on the clinical outcomes of Asian non-valvular atrial fibrillation patients: insights from the prospective multicentre COOL-AF registry
Krittayaphong, R., Phrommintikul, A., Winijkul, A., Methavigul, K., Komoltri, C., Kaewkumdee, P., & Yindeengam, A. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-043862 · Cited by 6
Suprachoroidal Hemorrhage after XEN Gel Implant Requiring Surgical Drainage
Sarrafpour, S., Wang, K. K., & Wang, J. C. (2022) · JOURNAL OF CURRENT GLAUCOMA PRACTICE · doi:10.5005/jp-journals-10078-1378 · Cited by 6
Periprocedural Anticoagulation
Parks, A. L., & Fang, M. C. (2023) · Annals of Internal Medicine · doi:10.7326/aitc202304180 · Cited by 6
Left atrial appendage closure in very elderly patients in the French National Registry
Teíger, E., Eschalier, R., Amabile, N., Rioufol, G., Ducrocq, G., Garot, P., Lepillier, A., Bille, J., Elbaz, M., Defaye, P., et al. (2023) · Heart · doi:10.1136/heartjnl-2023-322871 · Cited by 6
Selection of Non-vitamin K Antagonist Oral Anticoagulant for Stroke Prevention in Atrial Fibrillation Based on Patient Profile: Perspectives from Vietnamese Experts. Part 1
Ho, T. H. Q., Ton, M. T., Nguyen, V. L., Pham, H. M., Hoang, S. V., Vo, N. T., Nguyen, T. Q., Pham, L. T., Mai, T. D., & Nguyen, T. H. (2023) · European Cardiology Review · doi:10.15420/ecr.2023.24 · Cited by 6
Screening for atrial fibrillation in care homes using pulse palpation and the AliveCor Kardia Mobile® device: a comparative cross-sectional pilot study
Savickas, V., Stewart, A. J., Short, V. J., Mathie, A. A., Bhamra, S. K., Veale, E. L., & Corlett, S. A. (2023) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-023-01672-z · Cited by 6
Left atrial appendage occlusion in patients suffering from advanced chronic kidney disease (stage 4 and 5). Long‐term follow‐up
López‐Tejero, S., Muiños, P. J. A., Gómez, P. F., Sousa, G. B.-D., Rodríguez‐Collado, J., Herrero‐Garibi, J., Blanco-Fernández, F., Diego‐Nieto, A., Lapeira, G. D., del Villar‐Moro, M. C. P., et al. (2024) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.30946 · Cited by 6
Development and Validation of a New Nomogram Model for Predicting Acute Ischemic Stroke in Elderly Patients with Non-Valvular Atrial Fibrillation: A Single-Center Cross-Sectional Study
Guo, J., Zhou, Y., & Zhou, B. (2024) · Clinical Interventions in Aging · doi:10.2147/cia.s437065 · Cited by 6
LAA occlusion is effective and safe in very high-risk atrial fibrillation patients with prior stroke: results from the multicentre German LAARGE registry
Ansari, U., Brachmann, J., Lewalter, T., Zeymer, U., Sievert, H., Ledwoch, J., Geist, V., Hochadel, M., Schneider, S., Senges, J., et al. (2024) · Clinical Research in Cardiology · doi:10.1007/s00392-024-02376-8 · Cited by 6
A review of apixaban for stroke prevention in atrial fibrillation: insights from ARISTOTLE
Hess, C. N., Al‐Khatib, S. M., Granger, C. B., & Lópes, R. D. (2013) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2013.824181 · Cited by 6
Using the CHA2DS2-VASc score for stroke risk stratification in atrial fibrillation: a clinical perspective
Lip, G. Y. H. (2013) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.13.13 · Cited by 6
Self-citation
Cost-Effectiveness of Bridging Anticoagulation Among Patients with Nonvalvular Atrial Fibrillation
Pappas, M. A., Barnes, G. D., & Vijan, S. S. (2019) · Journal of General Internal Medicine · doi:10.1007/s11606-018-4796-9 · Cited by 6

Authors: Friberg, L., Rosenqvist, M., & Lip, G. Y. H.
Affiliations: Danderyds sjukhus (SE)
Karolinska Institutet (SE)
Birmingham City Hospital (GB)
Corresponding author: Lip, Gregory Y.H.
ORCID: Friberg, Leif
Lip, Gregory Y.H.
Venue: European Heart Journal
Publisher: Oxford University Press (OUP)
Published: 2012-01-13
Volume: 33
Issue: 12
Pages: 1500-1510
ISSN: 0195-668X (ISSN-L)
1522-9645
DOI: 10.1093/eurheartj/ehr488
OpenAlex: W2124601103
Cited by: 1,192
References: 48
Citations by year: 2026: 37 · 2025: 60 · 2024: 74 · 2023: 81 · 2022: 112 · 2021: 99 · 2020: 100 · 2019: 99 · 2018: 78 · 2017: 99 · 2016: 75 · 2015: 99 · 2014: 72 · 2013: 68 · 2012: 35
FWCI: 56.38
Type: journal article
Language: en
Open access: closed
Locations: European Heart Journal (publishedVersion)
PubMed (publishedVersion)
University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
Funders: Stockholms Läns Landsting
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
Keywords: atrial fibrillation, stroke risk stratification, bleeding risk stratification, CHA2DS2-VASc score, HAS-BLED score, thromboembolism, intracranial hemorrhage, risk factors, peripheral arterial disease, oral anticoagulants, thyroid dysfunction, hyperthyroidism, concordance index
MeSH terms: Adult, Aged, Anticoagulants, Atrial Fibrillation, Female, Hemorrhage, Humans, Male, Middle Aged, Risk Factors, Sweden, Thromboembolism, Cohort Studies, Risk Assessment, Stroke

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks